Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
What sbir.gov is good for: Cross-agency browsing of currently open topics Looking up past awards (who won what, for how much) Reading the SBIR Policy Directive and SBA guidance Finding agency program office contacts What sbir.gov is not good for: Submitting proposals almost every agency routes you out to a specific portal (DSIP, eRA Commons, NSPIRES, Research.gov, PAMS, Grants.gov) Real-time alerts that match your actual technology focus Eligibility filtering at the company level Tracking topic amendments, Q&A releases, or pre-release period activity Treat sbir.gov as the catalog
The peptides versus steroids comparison explores these differences in detail
Matthews DR, Paldnius PM, Proot P et al (2019) Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
As more studies come out, were seeing that Retatrutide is safe and works well
Ushakumari and Sladen 2024
